CY1110538T1 - S-μιρταζαπινη για τη θεραπεια των εξαψεων - Google Patents

S-μιρταζαπινη για τη θεραπεια των εξαψεων

Info

Publication number
CY1110538T1
CY1110538T1 CY20091101044T CY091101044T CY1110538T1 CY 1110538 T1 CY1110538 T1 CY 1110538T1 CY 20091101044 T CY20091101044 T CY 20091101044T CY 091101044 T CY091101044 T CY 091101044T CY 1110538 T1 CY1110538 T1 CY 1110538T1
Authority
CY
Cyprus
Prior art keywords
mirtazapin
extra treatment
mirtazapine
extra
treatment
Prior art date
Application number
CY20091101044T
Other languages
Greek (el)
English (en)
Inventor
Bwmm Bernardus Peeters
Anton Egbert Peter Adang
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1110538(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of CY1110538T1 publication Critical patent/CY1110538T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CY20091101044T 2004-11-15 2009-10-12 S-μιρταζαπινη για τη θεραπεια των εξαψεων CY1110538T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15
EP05808013A EP1814555B1 (en) 2004-11-15 2005-11-14 S-mirtazapine for the treatment of hot flush

Publications (1)

Publication Number Publication Date
CY1110538T1 true CY1110538T1 (el) 2015-04-29

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101044T CY1110538T1 (el) 2004-11-15 2009-10-12 S-μιρταζαπινη για τη θεραπεια των εξαψεων

Country Status (30)

Country Link
US (4) US20070265245A1 (enExample)
EP (1) EP1814555B1 (enExample)
JP (1) JP2008519810A (enExample)
KR (1) KR20070085470A (enExample)
CN (2) CN101056641A (enExample)
AR (1) AR053780A1 (enExample)
AT (1) ATE439843T1 (enExample)
AU (1) AU2005303778B2 (enExample)
BR (1) BRPI0517818A2 (enExample)
CA (1) CA2587283C (enExample)
CY (1) CY1110538T1 (enExample)
DE (1) DE602005016141D1 (enExample)
DK (1) DK1814555T3 (enExample)
ES (1) ES2329815T3 (enExample)
HR (1) HRP20090513T1 (enExample)
IL (1) IL182767A (enExample)
MX (1) MX2007005827A (enExample)
MY (1) MY144089A (enExample)
NO (1) NO20072285L (enExample)
NZ (1) NZ554858A (enExample)
PE (1) PE20061051A1 (enExample)
PL (1) PL1814555T3 (enExample)
PT (1) PT1814555E (enExample)
RS (1) RS51138B (enExample)
RU (1) RU2396957C2 (enExample)
SI (1) SI1814555T1 (enExample)
TW (1) TW200631584A (enExample)
UA (1) UA88655C2 (enExample)
WO (1) WO2006051111A1 (enExample)
ZA (1) ZA200703884B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002174A2 (en) * 2005-06-27 2007-01-04 N.V. Organon. A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
EP1993556A1 (en) * 2006-03-06 2008-11-26 N.V. Organon An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
AU2007324467A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
JP6876003B2 (ja) 2015-02-27 2021-05-26 デクラ リミテッド イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置
KR102608479B1 (ko) * 2017-05-25 2023-12-01 글리테크 엘엘씨. Nmdar 길항제-반응성 신경정신 질환을 위한 병용 요법
WO2021167579A1 (ru) 2020-02-19 2021-08-26 Иван УЛИНИЧ Универсальное устройство для тепловой обработки пищевых продуктов

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
ES2212550T3 (es) * 1998-04-02 2004-07-16 Akzo Nobel N.V. Solucion oral liquida que comprende el antidepresor mirtazapina.
RU2195951C1 (ru) * 2001-08-20 2003-01-10 Общество с ограниченной ответственностью "Лаборатория "Ирис" Средство для лечения климактерических расстройств

Also Published As

Publication number Publication date
AR053780A1 (es) 2007-05-23
CN102772414A (zh) 2012-11-14
MX2007005827A (es) 2007-07-20
ES2329815T3 (es) 2009-12-01
CA2587283A1 (en) 2006-05-18
EP1814555B1 (en) 2009-08-19
CA2587283C (en) 2013-01-15
US20100267694A1 (en) 2010-10-21
HRP20090513T1 (hr) 2009-10-31
US20070265245A1 (en) 2007-11-15
PT1814555E (pt) 2009-09-30
NZ554858A (en) 2009-10-30
ATE439843T1 (de) 2009-09-15
PL1814555T3 (pl) 2010-01-29
IL182767A (en) 2011-07-31
KR20070085470A (ko) 2007-08-27
PE20061051A1 (es) 2006-10-26
MY144089A (en) 2011-08-15
IL182767A0 (en) 2007-09-20
UA88655C2 (ru) 2009-11-10
NO20072285L (no) 2007-06-13
CN101056641A (zh) 2007-10-17
RU2396957C2 (ru) 2010-08-20
RS51138B (sr) 2010-10-31
US20120302552A1 (en) 2012-11-29
HK1104235A1 (en) 2008-01-11
US20130225559A1 (en) 2013-08-29
DE602005016141D1 (de) 2009-10-01
AU2005303778A1 (en) 2006-05-18
EP1814555A1 (en) 2007-08-08
AU2005303778B2 (en) 2011-02-17
RU2007122391A (ru) 2008-12-20
JP2008519810A (ja) 2008-06-12
DK1814555T3 (da) 2009-12-07
SI1814555T1 (sl) 2009-12-31
WO2006051111A1 (en) 2006-05-18
ZA200703884B (en) 2009-07-29
TW200631584A (en) 2006-09-16
BRPI0517818A2 (pt) 2010-03-16

Similar Documents

Publication Publication Date Title
CY1115299T1 (el) Αναστολεις mtor στη θεραπεια των ενδοκρινικων ογκων
CY1109741T1 (el) Sns-595 και μεθοδοι χρησης αυτου
CY1120904T1 (el) Βελτιωμενη γελη τεστοστερονης και μεθοδος χρησεως στην αγωγη του υπογοναδισμου
CY1114401T1 (el) Αντιμετωπιση τυπου 2 διαβητη με ενα συνδυασμο dpiv αναστολεα και μετφορμινης ή θειαζολιδινοδιονης
CY1118472T1 (el) Υποκατεστημενα ακυλανιλιδια και μεθοδοι χρησης αυτων
CY1117817T1 (el) Υποκατεστημενα ακυλανιλιδια και μεθοδοι χρησης αυτων
CY1115059T1 (el) Θεραπευτικα απταμερη χρησιμα στην θεραπευτικη αγωγη διαταραχων σχετιζομενων με συμπληρωμα
CY1120022T1 (el) Θεραπεια παιδιατρικης οξειας λεμφοβλαστικης λευχαιμιας
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
CY1110889T1 (el) C-αρυλο γλυκοζιτικοι sglt2 αναστολεις και μεθοδος για την παραγωγη τους
CY1115871T1 (el) Μεθοδοι για την αντιμετωπιση ουρικης αρθριτιδας
CY1112643T1 (el) Διενυδρη υδροχλωρικη ναλμεφαινη
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
CY1118349T1 (el) Παραγοντες συνδεσης me cd19 και χρησεις αυτων
ATE539752T1 (de) Verwendung von pi3k- und mek-modulatoren bei der krebsbehandlung
CY1124281T1 (el) Θεραπευτικη χρηση ειδικου προσδετη σε σχετικες me msrv ασθενειες
NO20072285L (no) S-mirtazapin for behandling av hetetokter
CY1113426T1 (el) Παραγωγα βενζοθειαζεπινης ως αναστολεις υποδοχεα ρυανοδινης (ryr2) και χρηση αυτων στη θεραπεια καρδιακων ασθενειων
ATE541597T1 (de) Implantierbare vorrichtung mit sich langsam auflösendem polymer
CY1109240T1 (el) Συνδυασμος που περιλαμβανει βαλσαρτανη, αμλοδιπινη και υδροχλωροθειαζιδιο
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
ATE439868T1 (de) Targetingmittel für molekulare bilderzeugung
CY1114920T1 (el) Φαρμακευτικη συνθεση που περιεχει λακοσαμιδη και λεβετιρακεταμη με συνεργιστικη αντισπασμωδικη δραση
CY1113930T1 (el) Ενωσεις χρησιμες στην αναστολη της chk1
CY1113314T1 (el) (3-αρυλ-πιπεραζιν-1-υλ) παραγωγα της 6,7-διαλκοξυκιναζολινης, 6,7-διαλκοξυφθαλαζινης και 6,7-διαλκοξυϊσοκινολινης